Jevtana and Provenge

New prostate cancer drugs come to market quite rarely because the studies mandated by the FDA cost hundreds of millions of dollars. The FDA requires these studies to randomly allocate men into two comparison groups. One group receives the new medicine being tested. The other group gets an ineffective fake, called a placebo.  READ THE FULL ARTICLE HERE > https://www.verywell.com/jevtana-and-provenge-2782328 

Leave a Reply

Your email address will not be published.